GRPR-targeting radiotheranostics for breast cancer management
A D'Onofrio, S Engelbrecht, T Läppchen… - Frontiers in …, 2023 - frontiersin.org
Breast Cancer (BC) is the most common cancer worldwide and, despite the advancements
made toward early diagnosis and novel treatments, there is an urgent need to reduce its …
made toward early diagnosis and novel treatments, there is an urgent need to reduce its …
[HTML][HTML] Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review
C Baun, M Naghavid-Behzad, MG Hildebrandt… - Seminars in Nuclear …, 2024 - Elsevier
The gastrin-releasing peptide receptor (GRPR) is known to be overexpressed in breast
cancer, making it a promising target for both imaging and therapy within a theranostic …
cancer, making it a promising target for both imaging and therapy within a theranostic …
Bombesin receptors in GtoPdb v. 2023.1
J Battey, RV Benya, RT Jensen… - IUPHAR/BPS Guide to …, 2023 - journals.ed.ac.uk
Mammalian bombesin (Bn) receptors comprise 3 subtypes: BB 1, BB 2, BB 3 (nomenclature
recommended by the NC-IUPHAR Subcommittee on bombesin receptors,[117, 4]). BB 1 and …
recommended by the NC-IUPHAR Subcommittee on bombesin receptors,[117, 4]). BB 1 and …